HealthDay (1/18, Thompson) reports that patients with prostate cancer “treated with the latest forms of hormone blockers were twice as likely to develop depression compared with men treated with older forms of hormone therapy or those who received no such medication at all, results from a new study show.” The findings were published in JAMA. (SOURCE: APA Headlines)